Article Information
History
- August 15, 2024.
Article Versions
- Version 1 (July 31, 2024 - 21:32).
- You are currently viewing Version 2 of this article (August 15, 2024 - 20:56).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hannah A. DeBerg1,
- Mitch L. Fahning2,
- James D. Schlenker3,
- William P. Schmitt3,
- Iris K. Gratz2,4,5,6,
- Jeffrey S. Carlin7,8,
- Daniel J. Campbell2,9 and
- Peter A. Morawski2,*
- 1Center for Systems Immunology, Benaroya Research Institute, Seattle, Washington, USA
- 2Center for Fundamental Immunology, Benaroya Research Institute, Seattle, Washington, USA
- 3Plastic and Reconstructive Surgery, Virginia Mason Medical Center, Seattle, Washington, USA
- 4Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria
- 5EB House Austria, Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria
- 6Center for Tumor Biology and Immunology, University of Salzburg, Salzburg, Austria
- 7Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington, USA
- 8Division of Rheumatology, Virginia Mason Medical Center, Seattle, Washington, USA
- 9Department of Immunology, University of Washington School of Medicine, Seattle, Washington, USA
- ↵*Correspondence: 1201 9th Ave, Seattle, Washington 98101, USA; Phone: 1(206)287-1052; E-mail: pmorawski{at}benaroyaresearch.org